Document is current
Any future updates will be listed below
-
Authors
Brothers, Thomas D. https://orcid.org/0000-0002-5570-5556
Walley, Alexander Y.
Rivers-Bowerman, Helen
McLeod, Magnus
Genge, Leah
-
Funding
Funding for this research was provided by:
Dalhousie University Internal Medicine Research Foundation (Fellowship)
Canadian Institutes of Health Research (CIHR-FRN# 171259)
National Institute on Drug Abuse (R25DA033211)
- License Information
-
More Information
Article History
Received: 9 November 2022
Accepted: 17 February 2023
First Online: 6 March 2023
Declarations
:
: We thank the patient for providing signed, informed consent for publication. This case report was deemed exempt from requirement for research ethics board review by the Nova Scotia Health Research Ethics Board (REB FILE #: 1028644).
: We thank the patient for providing signed, informed consent for publication.
: MM is the principal investigator in trials funded by Pfizer, Advanz, Allergan and NovoNordisk. MM has been on advisory boards/received honouraria from Advanz, Gilead, Eli Lilly, Eisai, NovoNordisk, Abbvie, and Lupin. The remaining authors declare they have no competing interests.
